Tiny machines in bacteria could help make new medicines

Tiny machines in bacteria could help make new medicines
Crystal structure of the NRPS complex. Credit: Canadian Light Source

With the help of the Canadian Light Source (CLS) at the University of Saskatchewan, researchers from McGill University are trying to unlock the full potential of tiny biological machines that can have a huge impact on human health.

These machines—known as nonribosomal peptide synthetases (NRPSs)—are critical for creating therapeutic molecules found in a variety of medicines, from antibiotics to immunosuppressants.

“Microbes like bacteria and fungi have these NRPS machines that are responsible for making molecules that act as important drugs and therapeutics,” said Camille Fortinez, a recent Ph.D. graduate of McGill’s Department of Biochemistry and lead author on a paper published in Nature Communications.

Understanding how NRPSs create therapeutics will help researchers to design new drugs and to combat global health issues like antibiotic resistance.

With the help of the CMCF beamline at the CLS, Martin Schmeing, Professor of Biochemistry at McGill, and Fortinez were able to look at one common NRPS machine in great detail.

“CLS has allowed us to get a really high-resolution diffraction of our NRPS crystals,” Fortinez said. “This high resolution is really integral for allowing us to answer questions and better understand the NRPS.”

The team analyzed an NRPS found in many bacteria that helps generate a chemical that kills algae. In the process, Fortinez and Schmeing discovered that a separate enzyme is responsible for a crucial stage in the production of this algae-killing compound.

Tiny machines in bacteria could help make new medicines. Credit: Canadian Light Source

The NRPS machines that the team studied could help to develop new therapeutics and the algae-killing compound might be modified to kill bacteria that threaten our health. The researchers are hopeful that the detailed data they collected will help to lead the way.

“The CLS is a wonderful national resource that we are deeply indebted to and it’s a really important resource to keep Canadian science doing as well as we are doing,” Schmeing said.

Better understanding of nature’s nanomachines may help in design of future drugs

More information:
Camille Marie Fortinez et al, Structures and function of a tailoring oxidase in complex with a nonribosomal peptide synthetase module, Nature Communications (2022). DOI: 10.1038/s41467-022-28221-y

Provided by
Canadian Light Source

Tiny machines in bacteria could help make new medicines (2022, April 1)
retrieved 2 April 2022
from https://phys.org/news/2022-04-tiny-machines-bacteria-medicines.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.